Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Inhibrx Biosciences, Inc. (INBX) had Weighted-Average Shares Outstanding (Diluted) of 14.98M for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
$0.20M |
|
$1.69B |
|
-- |
|
$0.20M |
|
$331.65M |
|
$-331.45M |
|
$2.02B |
|
$1.69B |
|
$1.69B |
|
$1.69B |
|
$1.69B |
|
$1.69B |
|
$1.69B |
|
$-331.45M |
|
$-329.16M |
|
14.80M |
|
Weighted-Average Shares Outstanding (Diluted) |
14.98M |
$114.01 |
|
$112.62 |
|
Balance Sheet Financials | |
$160.40M |
|
$6.20M |
|
$20.37M |
|
$180.77M |
|
$40.73M |
|
-- |
|
$6.45M |
|
$47.18M |
|
$133.58M |
|
$133.58M |
|
$133.58M |
|
14.48M |
|
Cash Flow Statement Financials | |
$-194.41M |
|
$-2.60M |
|
$71.68M |
|
$277.92M |
|
$152.60M |
|
$-125.33M |
|
$58.52M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
3.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-165724.00% |
|
-165724.00% |
|
-164581.50% |
|
843787.00% |
|
843786.10% |
|
$-197.01M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.48 |
|
766.50 |
|
1263.30% |
|
1263.30% |
|
933.56% |
|
1263.30% |
|
$9.23 |
|
$-13.15 |
|
$-12.97 |